Industry Research Reports

Home > Reports > Pharma & Healthcare > Plasmid - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Plasmid - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-14

Pages: 128 Pages

Report ld: 2632021

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Plasmid was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Plasmid was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Plasmid was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Plasmid was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Plasmid include Aldevron, GenScript, PlasmidFactory GmbH & Co. KG, VGXI Inc., Oxford Genetics Ltd., Applied StemCell, Altogen Biosystems, Cobra Biologics and Copernicus Therapeutics Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasmid, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Plasmid by region & country, by Type, and by Application.

The Plasmid market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid.

Market Segmentation

Report Metric
Details
Report Title
Plasmid - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Plasmid Companies Covered
Aldevron, GenScript, PlasmidFactory GmbH & Co. KG, VGXI Inc., Oxford Genetics Ltd., Applied StemCell, Altogen Biosystems, Cobra Biologics, Copernicus Therapeutics Inc., Takara Bio, InvivoGen, Miltenyi Biotec, Medigene Sdn Bhd, MaxCyte Inc., Mirus Bio LLC, MolMed S.p.A., GenePharma, Polyplus Transfection
Global Plasmid Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plasmid Market, Segment by Type
F-Plasmids

Col Plasmids

Resistance Plasmids

Cryptic Plasmids

Degradative Plasmids

Virulence Plasmids
Global Plasmid Market, Segment by Application
Transfection

Recombinant DNA Technology

Gene Therapy

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Plasmid manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Plasmid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Plasmid in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Plasmid Product Introduction
    1.2 Global Plasmid Market Size Forecast
    1.3 Plasmid Market Trends & Drivers
        1.3.1 Plasmid Industry Trends
        1.3.2 Plasmid Market Drivers & Opportunity
        1.3.3 Plasmid Market Challenges
        1.3.4 Plasmid Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Plasmid Players Revenue Ranking (2023)
    2.2 Global Plasmid Revenue by Company (2019-2024)
    2.3 Key Companies Plasmid Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Plasmid Product Offered
    2.5 Key Companies Time to Begin Mass Production of Plasmid
    2.6 Plasmid Market Competitive Analysis
        2.6.1 Plasmid Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Plasmid Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 F-Plasmids
        3.1.2 Col Plasmids
        3.1.3 Resistance Plasmids
        3.1.4 Cryptic Plasmids
        3.1.5 Degradative Plasmids
        3.1.6 Virulence Plasmids
    3.2 Global Plasmid Sales Value by Type
        3.2.1 Global Plasmid Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Plasmid Sales Value, by Type (2019-2030)
        3.2.3 Global Plasmid Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Transfection
        4.1.2 Recombinant DNA Technology
        4.1.3 Gene Therapy
        4.1.4 Others
    4.2 Global Plasmid Sales Value by Application
        4.2.1 Global Plasmid Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Plasmid Sales Value, by Application (2019-2030)
        4.2.3 Global Plasmid Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Plasmid Sales Value by Region
        5.1.1 Global Plasmid Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Plasmid Sales Value by Region (2019-2024)
        5.1.3 Global Plasmid Sales Value by Region (2025-2030)
        5.1.4 Global Plasmid Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Plasmid Sales Value, 2019-2030
        5.2.2 North America Plasmid Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Plasmid Sales Value, 2019-2030
        5.3.2 Europe Plasmid Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Plasmid Sales Value, 2019-2030
        5.4.2 Asia Pacific Plasmid Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Plasmid Sales Value, 2019-2030
        5.5.2 South America Plasmid Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Plasmid Sales Value, 2019-2030
        5.6.2 Middle East & Africa Plasmid Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Plasmid Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Plasmid Sales Value
    6.3 United States
        6.3.1 United States Plasmid Sales Value, 2019-2030
        6.3.2 United States Plasmid Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Plasmid Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Plasmid Sales Value, 2019-2030
        6.4.2 Europe Plasmid Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Plasmid Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Plasmid Sales Value, 2019-2030
        6.5.2 China Plasmid Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Plasmid Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Plasmid Sales Value, 2019-2030
        6.6.2 Japan Plasmid Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Plasmid Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Plasmid Sales Value, 2019-2030
        6.7.2 South Korea Plasmid Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Plasmid Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Plasmid Sales Value, 2019-2030
        6.8.2 Southeast Asia Plasmid Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Plasmid Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Plasmid Sales Value, 2019-2030
        6.9.2 India Plasmid Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Plasmid Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Aldevron
        7.1.1 Aldevron Profile
        7.1.2 Aldevron Main Business
        7.1.3 Aldevron Plasmid Products, Services and Solutions
        7.1.4 Aldevron Plasmid Revenue (US$ Million) & (2019-2024)
        7.1.5 Aldevron Recent Developments
    7.2 GenScript
        7.2.1 GenScript Profile
        7.2.2 GenScript Main Business
        7.2.3 GenScript Plasmid Products, Services and Solutions
        7.2.4 GenScript Plasmid Revenue (US$ Million) & (2019-2024)
        7.2.5 GenScript Recent Developments
    7.3 PlasmidFactory GmbH & Co. KG
        7.3.1 PlasmidFactory GmbH & Co. KG Profile
        7.3.2 PlasmidFactory GmbH & Co. KG Main Business
        7.3.3 PlasmidFactory GmbH & Co. KG Plasmid Products, Services and Solutions
        7.3.4 PlasmidFactory GmbH & Co. KG Plasmid Revenue (US$ Million) & (2019-2024)
        7.3.5 VGXI Inc. Recent Developments
    7.4 VGXI Inc.
        7.4.1 VGXI Inc. Profile
        7.4.2 VGXI Inc. Main Business
        7.4.3 VGXI Inc. Plasmid Products, Services and Solutions
        7.4.4 VGXI Inc. Plasmid Revenue (US$ Million) & (2019-2024)
        7.4.5 VGXI Inc. Recent Developments
    7.5 Oxford Genetics Ltd.
        7.5.1 Oxford Genetics Ltd. Profile
        7.5.2 Oxford Genetics Ltd. Main Business
        7.5.3 Oxford Genetics Ltd. Plasmid Products, Services and Solutions
        7.5.4 Oxford Genetics Ltd. Plasmid Revenue (US$ Million) & (2019-2024)
        7.5.5 Oxford Genetics Ltd. Recent Developments
    7.6 Applied StemCell
        7.6.1 Applied StemCell Profile
        7.6.2 Applied StemCell Main Business
        7.6.3 Applied StemCell Plasmid Products, Services and Solutions
        7.6.4 Applied StemCell Plasmid Revenue (US$ Million) & (2019-2024)
        7.6.5 Applied StemCell Recent Developments
    7.7 Altogen Biosystems
        7.7.1 Altogen Biosystems Profile
        7.7.2 Altogen Biosystems Main Business
        7.7.3 Altogen Biosystems Plasmid Products, Services and Solutions
        7.7.4 Altogen Biosystems Plasmid Revenue (US$ Million) & (2019-2024)
        7.7.5 Altogen Biosystems Recent Developments
    7.8 Cobra Biologics
        7.8.1 Cobra Biologics Profile
        7.8.2 Cobra Biologics Main Business
        7.8.3 Cobra Biologics Plasmid Products, Services and Solutions
        7.8.4 Cobra Biologics Plasmid Revenue (US$ Million) & (2019-2024)
        7.8.5 Cobra Biologics Recent Developments
    7.9 Copernicus Therapeutics Inc.
        7.9.1 Copernicus Therapeutics Inc. Profile
        7.9.2 Copernicus Therapeutics Inc. Main Business
        7.9.3 Copernicus Therapeutics Inc. Plasmid Products, Services and Solutions
        7.9.4 Copernicus Therapeutics Inc. Plasmid Revenue (US$ Million) & (2019-2024)
        7.9.5 Copernicus Therapeutics Inc. Recent Developments
    7.10 Takara Bio
        7.10.1 Takara Bio Profile
        7.10.2 Takara Bio Main Business
        7.10.3 Takara Bio Plasmid Products, Services and Solutions
        7.10.4 Takara Bio Plasmid Revenue (US$ Million) & (2019-2024)
        7.10.5 Takara Bio Recent Developments
    7.11 InvivoGen
        7.11.1 InvivoGen Profile
        7.11.2 InvivoGen Main Business
        7.11.3 InvivoGen Plasmid Products, Services and Solutions
        7.11.4 InvivoGen Plasmid Revenue (US$ Million) & (2019-2024)
        7.11.5 InvivoGen Recent Developments
    7.12 Miltenyi Biotec
        7.12.1 Miltenyi Biotec Profile
        7.12.2 Miltenyi Biotec Main Business
        7.12.3 Miltenyi Biotec Plasmid Products, Services and Solutions
        7.12.4 Miltenyi Biotec Plasmid Revenue (US$ Million) & (2019-2024)
        7.12.5 Miltenyi Biotec Recent Developments
    7.13 Medigene Sdn Bhd
        7.13.1 Medigene Sdn Bhd Profile
        7.13.2 Medigene Sdn Bhd Main Business
        7.13.3 Medigene Sdn Bhd Plasmid Products, Services and Solutions
        7.13.4 Medigene Sdn Bhd Plasmid Revenue (US$ Million) & (2019-2024)
        7.13.5 Medigene Sdn Bhd Recent Developments
    7.14 MaxCyte Inc.
        7.14.1 MaxCyte Inc. Profile
        7.14.2 MaxCyte Inc. Main Business
        7.14.3 MaxCyte Inc. Plasmid Products, Services and Solutions
        7.14.4 MaxCyte Inc. Plasmid Revenue (US$ Million) & (2019-2024)
        7.14.5 MaxCyte Inc. Recent Developments
    7.15 Mirus Bio LLC
        7.15.1 Mirus Bio LLC Profile
        7.15.2 Mirus Bio LLC Main Business
        7.15.3 Mirus Bio LLC Plasmid Products, Services and Solutions
        7.15.4 Mirus Bio LLC Plasmid Revenue (US$ Million) & (2019-2024)
        7.15.5 Mirus Bio LLC Recent Developments
    7.16 MolMed S.p.A.
        7.16.1 MolMed S.p.A. Profile
        7.16.2 MolMed S.p.A. Main Business
        7.16.3 MolMed S.p.A. Plasmid Products, Services and Solutions
        7.16.4 MolMed S.p.A. Plasmid Revenue (US$ Million) & (2019-2024)
        7.16.5 MolMed S.p.A. Recent Developments
    7.17 GenePharma
        7.17.1 GenePharma Profile
        7.17.2 GenePharma Main Business
        7.17.3 GenePharma Plasmid Products, Services and Solutions
        7.17.4 GenePharma Plasmid Revenue (US$ Million) & (2019-2024)
        7.17.5 GenePharma Recent Developments
    7.18 Polyplus Transfection
        7.18.1 Polyplus Transfection Profile
        7.18.2 Polyplus Transfection Main Business
        7.18.3 Polyplus Transfection Plasmid Products, Services and Solutions
        7.18.4 Polyplus Transfection Plasmid Revenue (US$ Million) & (2019-2024)
        7.18.5 Polyplus Transfection Recent Developments

 8 Industry Chain Analysis
    8.1 Plasmid Industrial Chain
    8.2 Plasmid Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Plasmid Sales Model
        8.5.2 Sales Channel
        8.5.3 Plasmid Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Plasmid Market Trends
    Table 2. Plasmid Market Drivers & Opportunity
    Table 3. Plasmid Market Challenges
    Table 4. Plasmid Market Restraints
    Table 5. Global Plasmid Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Plasmid Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Plasmid Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Plasmid Product Type
    Table 9. Key Companies Time to Begin Mass Production of Plasmid
    Table 10. Global Plasmid Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Plasmid Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Plasmid Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Plasmid Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Plasmid Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Plasmid Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Plasmid Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Plasmid Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Plasmid Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Plasmid Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Plasmid Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Plasmid Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Plasmid Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Plasmid Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Plasmid Sales Value by Region (2019-2024) & (%)
    Table 27. Global Plasmid Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Plasmid Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Plasmid Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Plasmid Sales Value, (2025-2030) & (US$ Million)
    Table 31. Aldevron Basic Information List
    Table 32. Aldevron Description and Business Overview
    Table 33. Aldevron Plasmid Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Plasmid Business of Aldevron (2019-2024)
    Table 35. Aldevron Recent Developments
    Table 36. GenScript Basic Information List
    Table 37. GenScript Description and Business Overview
    Table 38. GenScript Plasmid Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Plasmid Business of GenScript (2019-2024)
    Table 40. GenScript Recent Developments
    Table 41. PlasmidFactory GmbH & Co. KG Basic Information List
    Table 42. PlasmidFactory GmbH & Co. KG Description and Business Overview
    Table 43. PlasmidFactory GmbH & Co. KG Plasmid Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Plasmid Business of PlasmidFactory GmbH & Co. KG (2019-2024)
    Table 45. PlasmidFactory GmbH & Co. KG Recent Developments
    Table 46. VGXI Inc. Basic Information List
    Table 47. VGXI Inc. Description and Business Overview
    Table 48. VGXI Inc. Plasmid Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Plasmid Business of VGXI Inc. (2019-2024)
    Table 50. VGXI Inc. Recent Developments
    Table 51. Oxford Genetics Ltd. Basic Information List
    Table 52. Oxford Genetics Ltd. Description and Business Overview
    Table 53. Oxford Genetics Ltd. Plasmid Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Plasmid Business of Oxford Genetics Ltd. (2019-2024)
    Table 55. Oxford Genetics Ltd. Recent Developments
    Table 56. Applied StemCell Basic Information List
    Table 57. Applied StemCell Description and Business Overview
    Table 58. Applied StemCell Plasmid Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Plasmid Business of Applied StemCell (2019-2024)
    Table 60. Applied StemCell Recent Developments
    Table 61. Altogen Biosystems Basic Information List
    Table 62. Altogen Biosystems Description and Business Overview
    Table 63. Altogen Biosystems Plasmid Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Plasmid Business of Altogen Biosystems (2019-2024)
    Table 65. Altogen Biosystems Recent Developments
    Table 66. Cobra Biologics Basic Information List
    Table 67. Cobra Biologics Description and Business Overview
    Table 68. Cobra Biologics Plasmid Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Plasmid Business of Cobra Biologics (2019-2024)
    Table 70. Cobra Biologics Recent Developments
    Table 71. Copernicus Therapeutics Inc. Basic Information List
    Table 72. Copernicus Therapeutics Inc. Description and Business Overview
    Table 73. Copernicus Therapeutics Inc. Plasmid Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Plasmid Business of Copernicus Therapeutics Inc. (2019-2024)
    Table 75. Copernicus Therapeutics Inc. Recent Developments
    Table 76. Takara Bio Basic Information List
    Table 77. Takara Bio Description and Business Overview
    Table 78. Takara Bio Plasmid Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Plasmid Business of Takara Bio (2019-2024)
    Table 80. Takara Bio Recent Developments
    Table 81. InvivoGen Basic Information List
    Table 82. InvivoGen Description and Business Overview
    Table 83. InvivoGen Plasmid Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Plasmid Business of InvivoGen (2019-2024)
    Table 85. InvivoGen Recent Developments
    Table 86. Miltenyi Biotec Basic Information List
    Table 87. Miltenyi Biotec Description and Business Overview
    Table 88. Miltenyi Biotec Plasmid Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Plasmid Business of Miltenyi Biotec (2019-2024)
    Table 90. Miltenyi Biotec Recent Developments
    Table 91. Medigene Sdn Bhd Basic Information List
    Table 92. Medigene Sdn Bhd Description and Business Overview
    Table 93. Medigene Sdn Bhd Plasmid Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Plasmid Business of Medigene Sdn Bhd (2019-2024)
    Table 95. Medigene Sdn Bhd Recent Developments
    Table 96. MaxCyte Inc. Basic Information List
    Table 97. MaxCyte Inc. Description and Business Overview
    Table 98. MaxCyte Inc. Plasmid Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Plasmid Business of MaxCyte Inc. (2019-2024)
    Table 100. MaxCyte Inc. Recent Developments
    Table 101. Mirus Bio LLC Basic Information List
    Table 102. Mirus Bio LLC Description and Business Overview
    Table 103. Mirus Bio LLC Plasmid Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Plasmid Business of Mirus Bio LLC (2019-2024)
    Table 105. Mirus Bio LLC Recent Developments
    Table 106. MolMed S.p.A. Basic Information List
    Table 107. MolMed S.p.A. Description and Business Overview
    Table 108. MolMed S.p.A. Plasmid Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Plasmid Business of MolMed S.p.A. (2019-2024)
    Table 110. MolMed S.p.A. Recent Developments
    Table 111. GenePharma Basic Information List
    Table 112. GenePharma Description and Business Overview
    Table 113. GenePharma Plasmid Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Plasmid Business of GenePharma (2019-2024)
    Table 115. GenePharma Recent Developments
    Table 116. Polyplus Transfection Basic Information List
    Table 117. Polyplus Transfection Description and Business Overview
    Table 118. Polyplus Transfection Plasmid Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Plasmid Business of Polyplus Transfection (2019-2024)
    Table 120. Polyplus Transfection Recent Developments
    Table 121. Key Raw Materials Lists
    Table 122. Raw Materials Key Suppliers Lists
    Table 123. Plasmid Downstream Customers
    Table 124. Plasmid Distributors List
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
    Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Plasmid Product Picture
    Figure 2. Global Plasmid Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Plasmid Sales Value (2019-2030) & (US$ Million)
    Figure 4. Plasmid Report Years Considered
    Figure 5. Global Plasmid Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Plasmid Revenue in 2023
    Figure 7. Plasmid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. F-Plasmids Picture
    Figure 9. Col Plasmids Picture
    Figure 10. Resistance Plasmids Picture
    Figure 11. Cryptic Plasmids Picture
    Figure 12. Degradative Plasmids Picture
    Figure 13. Virulence Plasmids Picture
    Figure 14. Global Plasmid Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Plasmid Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Transfection
    Figure 17. Product Picture of Recombinant DNA Technology
    Figure 18. Product Picture of Gene Therapy
    Figure 19. Product Picture of Others
    Figure 20. Global Plasmid Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Plasmid Sales Value Market Share by Application, 2023 & 2030
    Figure 22. North America Plasmid Sales Value (2019-2030) & (US$ Million)
    Figure 23. North America Plasmid Sales Value by Country (%), 2023 VS 2030
    Figure 24. Europe Plasmid Sales Value (2019-2030) & (US$ Million)
    Figure 25. Europe Plasmid Sales Value by Country (%), 2023 VS 2030
    Figure 26. Asia Pacific Plasmid Sales Value (2019-2030) & (US$ Million)
    Figure 27. Asia Pacific Plasmid Sales Value by Country (%), 2023 VS 2030
    Figure 28. South America Plasmid Sales Value (2019-2030) & (US$ Million)
    Figure 29. South America Plasmid Sales Value by Country (%), 2023 VS 2030
    Figure 30. Middle East & Africa Plasmid Sales Value (2019-2030) & (US$ Million)
    Figure 31. Middle East & Africa Plasmid Sales Value by Country (%), 2023 VS 2030
    Figure 32. Key Countries/Regions Plasmid Sales Value (%), (2019-2030)
    Figure 33. United States Plasmid Sales Value, (2019-2030) & (US$ Million)
    Figure 34. United States Plasmid Sales Value by Type (%), 2023 VS 2030
    Figure 35. United States Plasmid Sales Value by Application (%), 2023 VS 2030
    Figure 36. Europe Plasmid Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Europe Plasmid Sales Value by Type (%), 2023 VS 2030
    Figure 38. Europe Plasmid Sales Value by Application (%), 2023 VS 2030
    Figure 39. China Plasmid Sales Value, (2019-2030) & (US$ Million)
    Figure 40. China Plasmid Sales Value by Type (%), 2023 VS 2030
    Figure 41. China Plasmid Sales Value by Application (%), 2023 VS 2030
    Figure 42. Japan Plasmid Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Japan Plasmid Sales Value by Type (%), 2023 VS 2030
    Figure 44. Japan Plasmid Sales Value by Application (%), 2023 VS 2030
    Figure 45. South Korea Plasmid Sales Value, (2019-2030) & (US$ Million)
    Figure 46. South Korea Plasmid Sales Value by Type (%), 2023 VS 2030
    Figure 47. South Korea Plasmid Sales Value by Application (%), 2023 VS 2030
    Figure 48. Southeast Asia Plasmid Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Plasmid Sales Value by Type (%), 2023 VS 2030
    Figure 50. Southeast Asia Plasmid Sales Value by Application (%), 2023 VS 2030
    Figure 51. India Plasmid Sales Value, (2019-2030) & (US$ Million)
    Figure 52. India Plasmid Sales Value by Type (%), 2023 VS 2030
    Figure 53. India Plasmid Sales Value by Application (%), 2023 VS 2030
    Figure 54. Plasmid Industrial Chain
    Figure 55. Plasmid Manufacturing Cost Structure
    Figure 56. Channels of Distribution (Direct Sales, and Distribution)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation

Description

The global market for Plasmid was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Plasmid was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Plasmid was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Plasmid was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Plasmid include Aldevron, GenScript, PlasmidFactory GmbH & Co. KG, VGXI Inc., Oxford Genetics Ltd., Applied StemCell, Altogen Biosystems, Cobra Biologics and Copernicus Therapeutics Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasmid, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Plasmid by region & country, by Type, and by Application.

The Plasmid market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid.

Market Segmentation